Şunu aradınız:: bacteraemia (İngilizce - Maltaca)

bacteraemia
batteremija

aureus bacteraemia
batterimja b’ s. aureus

bacteria in the blood (bacteraemia)
batterji fid-demm (batteremija)

cssti without s. aureus bacteraemia
cssti mingħajr batterimja b’s. aureus

rare tuberculosis, bacteraemia, gastrointestinal infection
rari tuberkolożi, batteremija, infezzjoni gastrointestinali

- pyelonephritis is often associated with bacteraemia.
- il- pjelonefrite ħafna drabi tkun assoċjata ma 'batterjemija.

rie or cssti associated with s. aureus bacteraemia
rie jew cssti assoċjata ma’ batterimja b’s. aureus

- cssti with concurrent staphylococcus aureus bacteraemia:
- cssti b’ batterimja bi staphylococcus aureus fl- istess ħin:

one of these 60 patients had bacteraemia at baseline.
wieħed/waħda minn dawn is-60 pazjent kellu/ha batterimja fil-linja bażi.

- cssti without concurrent staphylococcus aureus bacteraemia:
- cssti mingħajr batterimja bi staphylococcus aureus fl- istess ħin:

it is not recommended to administer rienso to patients with ongoing bacteraemia.
mhux irrakkomandat li jingħata rienso lill-pazjenti b’batterimja preżenti.

device-related infection, infection susceptibility increased, bacteraemia, enterocolitis
infezzjoni relatati mat- tagħmir, żieda fis- suxxettibilità għall

a total of 81 cuti patients (7.4%) had bacteraemia at baseline.
total ta’ 81 pazjent b’cuti (7.4%) kellhom il-batterimja fil-linja bażi.

- staphylococcus aureus bacteraemia (sab) when associated with rie or with cssti.
- batterimja minn staphylococcus aureus (sab) meta tkun assoċjata ma ’ rie jew ma ’ cssti.

limited experience is also available in treating patients with concurrent bacteraemia (3%).
hemm ukoll esperjenza ristretta fit- trattament ta ’ pazjenti b’ batterimja konkomitanti (3%).

failures with daptomycin in the treatment of enterococcal infections that were mostly accompanied by bacteraemia have been reported.
fallimenti b’daptomycin fil-kura ta’ infezzjonijiet b’enterokokki li ħafna minnhom kellhom ukoll batterimja kienu rrappurtati.

adult patients with staphylococcus aureus bacteraemia (sab) when associated with rie or with cssti.
pazjenti adulti b’batterimja minn staphylococcus aureus (sab) meta tkun assoċjata ma’ rie jew ma’ cssti.

staphylococcal bacteraemia tuberculosis bronchopneumonia herpes ophthalmicus beta haemolytic streptococcal infection candidiasis genital candidiasis urinary tract infection cystitis body tinea
batterimja kkawżata minn staphyloccus tuberkulosi bronkopnewmonja herpes ophthalmicus infezzjoni emolitika beta kkawżata minn streptococcus kandidajasi kandidajasi ġenitali infezzjoni fl- apparat urinarju Ċistite tinea tal- ġisem nasofarinġite rinite

for endocarditis and for skin or soft tissue infection with bacteraemia, the dose is 6 mg/kg every 24 hours.
għal endocardite u għal infezzjoni b’batterjemija fil-ġilda jew fit-tessuti rotob, id-doża hija ta’ 6 mg/kg kull 24 siegħa.

approximately 87% of patients had apache ii scores of ≤ 10 and 4.0% had bacteraemia at baseline.
bejn wieħed u ieħor 87% tal-pazjenti ciai kellhom punteġġi apache ii ta’ ≤ 10 u 4.0% kellhom il-batterimja fil-linja bażi.